Kusuri No Aoki Reports No Share Buybacks Yet Under Authorized Program

The latest update is out from KUSURI NO AOKI HOLDINGS CO.,LTD. ( (JP:3549) ).

Kusuri No Aoki Holdings Co., Ltd. reported on the status of its share buyback program authorized under Article 459 of the Companies Act and its Articles of Incorporation, as approved by the board on December 25, 2025. The authorization permits market purchases of up to 6 million shares, or 6.32% of outstanding stock excluding treasury shares, with a cap of ¥24 billion in acquisition costs through December 25, 2026.

For the most recent reporting period from April 1 to April 30, 2026, the company did not acquire any of its own shares, resulting in zero shares purchased and zero yen spent under the program to date. This indicates that while Kusuri No Aoki retains the flexibility to execute a sizable buyback, market conditions or other considerations have so far led management to refrain from deploying capital for treasury share purchases, leaving the potential impact on shareholder returns and capital structure still unrealized.

The most recent analyst rating on (JP:3549) stock is a Hold with a Yen4200.00 price target. To see the full list of analyst forecasts on KUSURI NO AOKI HOLDINGS CO.,LTD. stock, see the JP:3549 Stock Forecast page.

More about KUSURI NO AOKI HOLDINGS CO.,LTD.

Kusuri No Aoki Holdings Co., Ltd. operates in Japan’s drugstore and pharmacy retail sector, focusing on the sale of pharmaceuticals, daily necessities, and related health and lifestyle products. Listed on the Tokyo Stock Exchange Prime market, the company targets consumers seeking convenient access to medicines and everyday goods across its store network.

Average Trading Volume: 267,446

Technical Sentiment Signal: Buy

Current Market Cap: Yen357.1B

See more data about 3549 stock on TipRanks’ Stock Analysis page.